Gene · 9376
Papers2,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates. | Res Sq | 2023 | 37790518 | PubTator, text mining | PubMed |
| The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies. | J Transl Med | 2023 | 37789439 | PubTator, text mining | PubMed |
| Ochratoxin A-The Current Knowledge Concerning Hepatotoxicity, Mode of Action and Possible Prevention. | Molecules | 2023 | 37764392 | PubTator, text mining | PubMed |
| Ovarian cancer in the older patient: where are we now? What to do next? | Ther Adv Med Oncol | 2023 | 37724138 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| Proteomic alterations in the brain and blood-brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer's disease. | Fluids Barriers CNS | 2023 | 37705104 | PubTator, text mining | PubMed |
| Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease. | Pharm Res | 2023 | 37704895 | PubTator, text mining | PubMed |
| Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacy. | PLOS Digit Health | 2023 | 37676853 | PubTator, text mining | PubMed |
| Favipiravir and hyperuricemia in patients with COVID-19-suggestions for future studies. | Lancet Reg Health Southeast Asia | 2023 | 37662055 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology. | Medicine (Baltimore) | 2023 | 37657024 | PubTator, text mining | PubMed |
| Elevated Maternal Testosterone Levels Alter PFOA Elimination and Tissue Distribution in Pregnant Rats. | J Environ Sci Public Health | 2023 | 37654976 | PubTator, text mining | PubMed |
| Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants. | Clin Transl Sci | 2023 | 37639334 | PubTator, text mining | PubMed |
Determination of furosemide and its glucuronide metabolite in plasma, plasma ultrafiltrate and urine by HPLC-MS/MS with application to secretion and metabolite formation clearances in non-pregnant and pregnant women. | J Pharm Biomed Anal | 2023 | 37634358 | PubTator, text mining | PubMed |
| Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review. | Viruses | 2023 | 37632074 | PubTator, text mining | PubMed |
| Machine Learning Techniques Applied to the Study of Drug Transporters. | Molecules | 2023 | 37630188 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers. | Int J Mol Sci | 2023 | 37628722 | PubTator, text mining | PubMed |
| Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker-Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease. | Clin Pharmacol Ther | 2023 | 37620246 | PubTator, text mining | PubMed |
| Chronic kidney disease and gut microbiota. | Heliyon | 2023 | 37609403 | PubTator, text mining | PubMed |
| Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates. | bioRxiv | 2023 | 37609337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9376/papers?page=10